Trial ID or NCT#

NCT01681121

Status

RECRUITING

Purpose

This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in the treatment of excessive daytime sleepiness in adults with narcolepsy.

Official Title

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Clete A. Kushida, MD, PhD, FAASM
Sleep specialist, Neurologist
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center
Chad Ruoff, MD

Contact us to find out if this trial is right for you.

CONTACT

Paul Stowers
(650) 721-7551